Pharmacogenomics in Clinical Practice: Evidence and Steps
A 2023 Lancet trial showed that a 12-gene pharmacogenomic panel cut clinically relevant adverse drug reactions by about 30%. Here is what the evidence shows, how Estonia returns PGx results to its population, and what implementation takes.